Discovery of the novel HLA‐A*11:454 allele, a variant of HLA‐A*11:01:01:01 , in a Russian individual
HLA · 2024
DOI: 10.1111/tan.15303 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Anastasiia Ananeva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation. Hauptthemen laut MEDLINE: HLA-A Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Charity fund «National Bone Marrow Donors Registry named after Vasya Perevoshchikov».
Abstract (Originalsprache)
One nucleotide substitution in codon 270 of HLA‐A*11:01:01:01 results in the novel allele, HLA‐A*11:454 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation.
- Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation.
ORCID-Profile: Anastasiia Ananeva, Elena I Shagimardanova
Förderung
- Charity fund «National Bone Marrow Donors Registry named after Vasya Perevoshchikov»
Zitieren
APA
Ananeva, A., Sergeeva, I., Andryushkina, A. V., & Shagimardanova, E. I. (2024). Discovery of the novel HLA‐A*11:454 allele, a variant of HLA‐A*11:01:01:01 , in a Russian individual. HLA. https://doi.org/10.1111/tan.15303
Vancouver
Ananeva A, Sergeeva I, Andryushkina AV, Shagimardanova EI. Discovery of the novel HLA‐A*11:454 allele, a variant of HLA‐A*11:01:01:01 , in a Russian individual. HLA. 2024. doi:10.1111/tan.15303
BibTeX
@article{Ananeva2024,
author = {Ananeva, Anastasiia and Sergeeva, Iuliia and Andryushkina, Anna V and Shagimardanova, Elena I},
title = {Discovery of the novel HLA‐A*11:454 allele, a variant of HLA‐A*11:01:01:01 , in a Russian individual},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15303}
}
EUVIMED